Inhibition of glycogen breakdown by imino sugars in vitro and in vivo.
The imino sugar N-butyldeoxynojirimycin (NB-DNJ) is a glucose analogue which inhibits the glycoprotein N-glycan processing enzymes alpha-glucosidases I and II and the ceramide glucosyltransferase that catalyses the first step of glycosphingolipid biosynthesis. This and other N-alkylated DNJ compound...
मुख्य लेखकों: | Andersson, U, Reinkensmeier, G, Butters, T, Dwek, R, Platt, F |
---|---|
स्वरूप: | Journal article |
भाषा: | English |
प्रकाशित: |
2004
|
समान संसाधन
-
Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses.
द्वारा: Butters, T, और अन्य
प्रकाशित: (2005) -
Therapeutic applications of imino sugars in lysosomal storage disorders.
द्वारा: Butters, T, और अन्य
प्रकाशित: (2003) -
Imino sugar therapy for type 1 Gaucher disease.
द्वारा: Priestman, D, और अन्य
प्रकाशित: (2000) -
Membrane disruption and cytotoxicity of hydrophobic N-alkylated imino sugars is independent of the inhibition of protein and lipid glycosylation.
द्वारा: Mellor, H, और अन्य
प्रकाशित: (2003) -
Molecular requirements of imino sugars for the selective control of N-linked glycosylation and glycosphingolipid biosynthesis
द्वारा: Butters, T, और अन्य
प्रकाशित: (2000)